Profund Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $980K | Buy |
|
|||||
|
2025
Q2 | $668K | Sell |
|
|||||
|
2025
Q1 | $752K | Buy |
|
|||||
|
2024
Q4 | $555K | Sell |
|
|||||
|
2024
Q3 | $870K | Sell |
|
|||||
|
2024
Q2 | $919K | Sell |
|
|||||
|
2024
Q1 | $1.15M | Sell |
|
|||||
|
2023
Q4 | $2.21M | Buy |
|
|||||
|
2023
Q3 | $1.21M | Sell |
|
|||||
|
2023
Q2 | $1.49M | Sell |
|
|||||
|
2023
Q1 | $1.18M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $226K | Sell |
|
|||||
|
2022
Q1 | $440K | Sell |
|
|||||
|
2021
Q4 | $471K | Sell |
|
|||||
|
2021
Q3 | $374K | Sell |
|
|||||
|
2021
Q2 | $571K | Buy |
|
|||||
|
2021
Q1 | $531K | Sell |
|
|||||
|
2020
Q4 | $1.26M | Buy |
|
|||||
|
2020
Q3 | $883K | Sell |
|
|||||
|
2020
Q2 | $1.22M | Buy |
|
|||||
|
2020
Q1 | $967K | Sell |
|
|||||
|
2019
Q4 | $1.38M | Buy |
|
|||||
|
2019
Q3 | $963K | Sell |
|
|||||
|
2019
Q2 | $797K | Sell |
|
|||||
|
2019
Q1 | $886K | Buy |
|
|||||
|
2018
Q4 | $532K | Sell |
|
|||||
|
2018
Q3 | $754K | Buy |
|
|||||
|
2018
Q2 | $513K | Buy |
|
|||||
|
2018
Q1 | $731K | Sell |
|
|||||
|
2017
Q4 | $1.08M | Sell |
|
|||||
|
2017
Q3 | $1.51M | Buy |
|
|||||
|
2017
Q2 | $1.01M | Sell |
|
|||||
|
2017
Q1 | $1.32M | Sell |
|
|||||
|
2016
Q4 | $1.2M | Sell |
|
|||||
|
2016
Q3 | $1.52M | Sell |
|
|||||
|
2016
Q2 | $1.56M | Sell |
|
|||||
|
2016
Q1 | $1.45M | Sell |
|
|||||
|
2015
Q4 | $2.07M | Sell |
|
|||||
|
2015
Q3 | $1.94M | Buy |
|